CO5640073A2 - Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad - Google Patents

Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad

Info

Publication number
CO5640073A2
CO5640073A2 CO05110248A CO05110248A CO5640073A2 CO 5640073 A2 CO5640073 A2 CO 5640073A2 CO 05110248 A CO05110248 A CO 05110248A CO 05110248 A CO05110248 A CO 05110248A CO 5640073 A2 CO5640073 A2 CO 5640073A2
Authority
CO
Colombia
Prior art keywords
modified starch
oralally
almidon
improvement
modified
Prior art date
Application number
CO05110248A
Other languages
English (en)
Inventor
David John Fadden
Neema Mahesh Kulkarni
Albert Frank Sorg
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of CO5640073A2 publication Critical patent/CO5640073A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Abstract

1.- Una película consumible adaptada para adherirse y disolverse en la cavidad oral de un animal de sangre caliente incluyendo los seres humanos, que comprende un almidón modificado y un agente farmacéuticamente activo.2.- La película consumible de la reivindicación 1, en la que el almidón modificado se selecciona del grupo constituido por un almidón modificado mecánicamente, un almidón modificado químicamente, un almidón modificado térmicamente y las combinaciones de los mismos.3.- La película consumible de la reivindicación 1, en la que el almidón modificado se selecciona de un almidón modificado químicamente.
CO05110248A 2003-05-02 2005-10-28 Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad CO5640073A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46733903P 2003-05-02 2003-05-02

Publications (1)

Publication Number Publication Date
CO5640073A2 true CO5640073A2 (es) 2006-05-31

Family

ID=33418443

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05110248A CO5640073A2 (es) 2003-05-02 2005-10-28 Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad

Country Status (19)

Country Link
US (1) US20040247648A1 (es)
EP (1) EP1622595A1 (es)
JP (1) JP2006525308A (es)
CN (1) CN1784218A (es)
AR (1) AR044131A1 (es)
AU (1) AU2004233744A1 (es)
BR (1) BRPI0409463A (es)
CA (1) CA2523372A1 (es)
CL (1) CL2004000931A1 (es)
CO (1) CO5640073A2 (es)
GT (1) GT200400085A (es)
MX (1) MXPA05010422A (es)
PA (1) PA8601801A1 (es)
PE (1) PE20050175A1 (es)
RU (1) RU2005129309A (es)
TW (1) TW200503786A (es)
UY (1) UY28304A1 (es)
WO (1) WO2004096193A1 (es)
ZA (1) ZA200507205B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
DE102004002951A1 (de) * 2004-01-21 2005-08-11 Wella Ag Verfahren zur Herstellung haarfestigender Produkte in Folienform
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
NZ588134A (en) * 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
WO2007143674A2 (en) * 2006-06-05 2007-12-13 Verus Pharmaceuticals, Inc. Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
US20070292481A1 (en) * 2006-06-16 2007-12-20 Hoffman Andrew J Packaging of Food Products with Pullulan Films
US20080152761A1 (en) * 2006-12-20 2008-06-26 Shiji Shen Packaging of Food Products with Pullulan Films
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
DE102006061287A1 (de) * 2006-12-22 2008-06-26 Lts Lohmann Therapie-Systeme Ag Eßbare folienförmige Zubereitung mit Cola-Geschmack
US20090011115A1 (en) * 2007-03-13 2009-01-08 Foss Carter D Edible Pullulan Films Containing Flavoring
WO2008127902A2 (en) * 2007-04-12 2008-10-23 Tate & Lyle Ingredients Americas, Inc. Pullulan film containing sweetener
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
JP2011506384A (ja) * 2007-12-11 2011-03-03 ノバルティス アーゲー マルチゾーンフィルム
US20110114657A1 (en) * 2009-11-13 2011-05-19 Nygaard Leann M Beverage container holder and edible film package assembly
JP2012031164A (ja) * 2010-07-06 2012-02-16 Teika Seiyaku Kk フィルム状製剤
AR083361A1 (es) * 2010-10-08 2013-02-21 Scherer Technologies Inc R P Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
WO2013028333A1 (en) * 2011-08-25 2013-02-28 Purebrands LLC Edible strips
CN102836144A (zh) * 2012-09-28 2012-12-26 天津市聚星康华医药科技有限公司 一种去氧肾上腺素口腔速溶膜及其制备方法
WO2015016727A2 (en) 2013-07-31 2015-02-05 Bluepharma - Industria Farmacêutica, S.A. Oral dispersible films
CN104530489B (zh) * 2015-02-05 2017-07-07 湖南尔康制药股份有限公司 一种速溶于水的淀粉成膜组合物
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
CN104983732B (zh) * 2015-05-28 2018-05-04 华润三九医药股份有限公司 一种布洛肾素那敏片及其制备方法
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
EP3939570A1 (en) * 2016-02-18 2022-01-19 Immune Therapeutics, Inc. Naltrexone for treating or preventing autoimmune and inflammatory diseases
EA202090637A1 (ru) 2017-09-08 2020-06-29 Инсайгнис Терапьютикс, Инк. Способы применения дипивефрина
CN113613630A (zh) 2019-03-01 2021-11-05 因斯格尼斯疗法有限公司 地匹福林口腔崩解片剂制剂
KR102221453B1 (ko) * 2019-07-19 2021-03-02 한국프라임제약주식회사 저분자 콜라겐 펩타이드 및 천연추출복합물을 포함하는 구강점막부착형 필름 조성물 및 이를 이용하여 제조된 구강점막부착형 필름

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US4197289A (en) * 1975-12-15 1980-04-08 Hoffmann-La Roche Inc. Novel dosage forms
US4562020A (en) * 1982-12-11 1985-12-31 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing self-supporting glucan film
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
JPH0739508B2 (ja) * 1986-11-11 1995-05-01 株式会社林原生物化学研究所 プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5354551A (en) * 1989-10-14 1994-10-11 Desitin Arzneimittel Gmbh Oral and dental hygiene preparation
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
JP3232488B2 (ja) * 1992-08-20 2001-11-26 株式会社林原生物化学研究所 プルラン高含有物とその製造方法並びに用途
US5411945A (en) * 1992-08-29 1995-05-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pullulan binder and its uses
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US6660292B2 (en) * 2001-06-19 2003-12-09 Hf Flavoring Technology Llp Rapidly disintegrating flavored film for precooked foods
US20030118653A1 (en) * 2001-07-06 2003-06-26 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
US6656493B2 (en) * 2001-07-30 2003-12-02 Wm. Wrigley Jr. Company Edible film formulations containing maltodextrin
EP1463490B1 (en) * 2001-10-12 2011-12-14 MonoSolRX, LLC Glucan based film delivery systems
ES2444951T5 (es) * 2001-10-12 2022-06-28 Aquestive Therapeutics Inc Películas uniformes para una forma farmacéutica de disolución rápida que incorpora composiciones de enmascaramiento del sabor
JP2003213038A (ja) * 2001-11-16 2003-07-30 Natl Starch & Chem Investment Holding Corp デンプンを含有するフィルム
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch

Also Published As

Publication number Publication date
TW200503786A (en) 2005-02-01
EP1622595A1 (en) 2006-02-08
MXPA05010422A (es) 2005-11-04
US20040247648A1 (en) 2004-12-09
RU2005129309A (ru) 2006-05-10
CA2523372A1 (en) 2004-11-11
AR044131A1 (es) 2005-08-24
ZA200507205B (en) 2006-11-29
GT200400085A (es) 2005-03-03
UY28304A1 (es) 2004-11-30
WO2004096193A1 (en) 2004-11-11
BRPI0409463A (pt) 2006-05-02
PE20050175A1 (es) 2005-03-21
CN1784218A (zh) 2006-06-07
CL2004000931A1 (es) 2005-01-07
AU2004233744A1 (en) 2004-11-11
JP2006525308A (ja) 2006-11-09
PA8601801A1 (es) 2004-11-26

Similar Documents

Publication Publication Date Title
CO5640073A2 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
UY28285A1 (es) Péliculas consumibles por vía oral que se disuelven rápidamente, que contienen un edulcorante
PE20061091A1 (es) FORMA CRISTALINA BETA-d DEL CLORHIDRATO DE IVABRANDINA, SU PROCEDIMIENTO DE PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
BRPI0412752A (pt) filmes de dissolução oral
ECSP045442A (es) "composiciones y metodo para el tratamiento de infección en ganado vacuno y porcino"
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
BR9811803A (pt) Comprido multiparticular aperfeiçoado de dissolução rápida
AR037407A1 (es) Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii
CO5700698A2 (es) Composiciones y metodos para el cuidado oral y personal
PA8625001A1 (es) Composiciones de pelicula
PA8502901A1 (es) Tratamiento de combinacion con il-1ra y compuestos que inhiben el procesamiento y la liberacion de il-1
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
BR9912275A (pt) Formulação de bioimplante
CR7678A (es) Heterociclilpyrimidinos sustituidos
DOP2005000085A (es) Composicion farmaceutica antimicobacterial
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
ECSP003685A (es) Formulaciones orales de liberacion controlada
BRPI0504082A (pt) emulsões refrescantes medicinais
DOP2004000897A (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejorade la resistencia al calor y a la humedad
BRPI0506710A (pt) composições farmacêuticas de liberação controlada
AR044009A1 (es) Combinacion farmaceutica que comprende eletriptan y bicarbonato de sodio
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa

Legal Events

Date Code Title Description
FC Application refused